Aggregated News
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first genetic optimization software that "helps parents pursuing IVF see and understand the complete genetic profile of each of their embryos."
Why It Matters
The company says it can analyze the genetic makeup of embryos to test for up to 900 conditions including diabetes, cancer, and heart disease. By choosing embryos with the lowest risk profiles, parents can theoretically boost their children's chances of living longer and healthier lives. But the practice also raises ethical concerns about choosing embryos based on probabilities.
"Nucleus Embryo is the first-ever genetic optimization software that helps parents give their children the best possible start in life—long before they're even born," the company said on X, formerly Twitter.
What To Know
Prospective parents can upload up to 20 embryo DNA files from their IVF clinics for over 900 genetic analyses spanning cancers, chronic conditions, appearance...